UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine
Abstract Introduction: Migraine is a primary headache disorder, which leads to diminished health‐related quality of life (HRQoL). There is limited…
Abstract Introduction: Migraine is a primary headache disorder, which leads to diminished health‐related quality of life (HRQoL). There is limited…
Abstract Background: Endometriosis, affecting 6%–10% of reproductive‐age women, causes chronic pelvic pain, dysmenorrhea, and infertility. Current treatments have limitations and…
Abstract Introduction: Fibromyalgia is a common condition characterised by widespread chronic pain, associated with comorbid mental health disorders and reduced…
Abstract Background: Although there is growing evidence supporting the use of cannabis‐based medicinal products (CBMPs) for the management of chronic…
Abstract Objectives: This study aims to assess differences in analgesia prescribing in UK primary care between individuals with osteoarthritis who…
Abstract Introduction: The growing opioid crisis and persistent global health disparities underscore the urgent need for alternative therapeutic strategies. Cannabis,…
Abstract Background: Complex regional pain syndrome is characterized by severe, persistent pain. Emerging evidence suggests that cannabis‐based medicinal products may…
Abstract Insomnia affects approximately 10% of adults globally. Current treatments have their limitations, and there is growing evidence on the…
Abstract Background: A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs)…
Abstract Objective: The study aims to evaluate the clinical outcomes in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers–Danlos…